Bruker Total Operating Expenses vs Net Income From Continuing Ops Analysis

BRKR Stock

USD 80.97 0.38 0.47%

Bruker financial indicator trend analysis is way more than just evaluating Bruker prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bruker is a good investment. Please check the relationship between Bruker Total Operating Expenses and its Net Income From Continuing Ops accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.

To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.

Total Operating Expenses vs Net Income From Continuing Ops

Total Operating Expenses vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bruker Total Operating Expenses account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have strong relationship.

The correlation between Bruker's Total Operating Expenses and Net Income From Continuing Ops is 0.62. Overlapping area represents the amount of variation of Total Operating Expenses that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Bruker, assuming nothing else is changed. The correlation between historical values of Bruker's Total Operating Expenses and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Operating Expenses of Bruker are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Total Operating Expenses i.e., Bruker's Total Operating Expenses and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

0.62

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Net Income From Continuing Ops

Most indicators from Bruker's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bruker current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.

To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.At this time, Bruker's Selling General Administrative is relatively stable compared to the past year. As of 04/27/2024, Sales General And Administrative To Revenue is likely to grow to 0.26, while Tax Provision is likely to drop slightly above 82.4 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.2B	1.3B	1.5B	1.6B
Total Revenue	2.4B	2.5B	3.0B	3.1B

Gross Profit Total Revenue

Bruker fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Inventory	Other Current Assets	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		0.97	0.96	0.42	0.85	0.34	0.96	-0.9	0.99	0.96	0.66	0.95	0.96	0.85	0.97	0.54	0.65	0.58	0.96	0.55	0.95	0.27	0.85	0.76	0.23	0.22
Total Stockholder Equity	0.97		0.92	0.38	0.75	0.49	0.88	-0.81	0.94	0.87	0.68	0.95	0.94	0.78	0.93	0.5	0.57	0.52	0.97	0.66	0.96	0.24	0.84	0.73	0.21	0.33
Non Current Assets Total	0.96	0.92		0.55	0.91	0.14	0.92	-0.95	0.95	0.94	0.52	0.91	0.98	0.95	0.98	0.53	0.44	0.35	0.95	0.37	0.91	0.14	0.95	0.57	0.24	0.14
Non Currrent Assets Other	0.42	0.38	0.55		0.51	-0.24	0.38	-0.46	0.42	0.44	-0.06	0.46	0.54	0.6	0.46	0.21	-0.05	-0.07	0.47	-0.1	0.39	-0.29	0.73	-0.04	0.3	-0.2
Other Assets	0.85	0.75	0.91	0.51		-0.11	0.9	-0.96	0.88	0.91	0.49	0.75	0.86	0.92	0.92	0.4	0.44	0.38	0.77	0.14	0.74	0.04	0.83	0.49	0.22	-0.12
Common Stock Shares Outstanding	0.34	0.49	0.14	-0.24	-0.11		0.16	0.04	0.27	0.13	0.42	0.44	0.27	-0.07	0.19	0.3	0.34	0.41	0.38	0.93	0.46	0.46	0.1	0.56	0.06	0.53
Non Current Liabilities Total	0.96	0.88	0.92	0.38	0.9	0.16		-0.94	0.98	0.99	0.69	0.84	0.9	0.84	0.96	0.43	0.72	0.66	0.87	0.39	0.84	0.22	0.78	0.75	0.22	0.17
Other Stockholder Equity	-0.9	-0.81	-0.95	-0.46	-0.96	0.04	-0.94		-0.92	-0.94	-0.54	-0.79	-0.89	-0.93	-0.96	-0.45	-0.5	-0.41	-0.85	-0.23	-0.79	-0.11	-0.84	-0.57	-0.31	-0.08
Total Liab	0.99	0.94	0.95	0.42	0.88	0.27	0.98	-0.92		0.98	0.65	0.93	0.95	0.86	0.97	0.54	0.67	0.61	0.93	0.49	0.93	0.28	0.84	0.76	0.23	0.17
Short Long Term Debt Total	0.96	0.87	0.94	0.44	0.91	0.13	0.99	-0.94	0.98		0.62	0.87	0.92	0.87	0.95	0.49	0.69	0.61	0.88	0.36	0.86	0.23	0.82	0.72	0.22	0.09
Other Current Liab	0.66	0.68	0.52	-0.06	0.49	0.42	0.69	-0.54	0.65	0.62		0.5	0.55	0.34	0.63	-0.1	0.76	0.75	0.55	0.6	0.56	-0.04	0.34	0.83	0.02	0.37
Total Current Liabilities	0.95	0.95	0.91	0.46	0.75	0.44	0.84	-0.79	0.93	0.87	0.5		0.95	0.82	0.88	0.68	0.5	0.44	0.96	0.61	0.99	0.37	0.87	0.68	0.22	0.15
Property Plant And Equipment Net	0.96	0.94	0.98	0.54	0.86	0.27	0.9	-0.89	0.95	0.92	0.55	0.95		0.91	0.95	0.54	0.46	0.38	0.96	0.47	0.96	0.18	0.95	0.61	0.24	0.15
Net Debt	0.85	0.78	0.95	0.6	0.92	-0.07	0.84	-0.93	0.86	0.87	0.34	0.82	0.91		0.91	0.51	0.26	0.18	0.86	0.17	0.8	0.05	0.94	0.39	0.28	-0.05
Retained Earnings	0.97	0.93	0.98	0.46	0.92	0.19	0.96	-0.96	0.97	0.95	0.63	0.88	0.95	0.91		0.46	0.54	0.49	0.93	0.42	0.88	0.14	0.88	0.65	0.27	0.2
Accounts Payable	0.54	0.5	0.53	0.21	0.4	0.3	0.43	-0.45	0.54	0.49	-0.1	0.68	0.54	0.51	0.46		0.22	0.12	0.57	0.4	0.63	0.81	0.5	0.37	0.22	0.11
Cash	0.65	0.57	0.44	-0.05	0.44	0.34	0.72	-0.5	0.67	0.69	0.76	0.5	0.46	0.26	0.54	0.22		0.96	0.45	0.48	0.51	0.38	0.21	0.9	0.01	0.26
Cash And Short Term Investments	0.58	0.52	0.35	-0.07	0.38	0.41	0.66	-0.41	0.61	0.61	0.75	0.44	0.38	0.18	0.49	0.12	0.96		0.38	0.52	0.43	0.31	0.14	0.87	0.04	0.21
Net Receivables	0.96	0.97	0.95	0.47	0.77	0.38	0.87	-0.85	0.93	0.88	0.55	0.96	0.96	0.86	0.93	0.57	0.45	0.38		0.57	0.96	0.23	0.91	0.64	0.32	0.28
Common Stock Total Equity	0.55	0.66	0.37	-0.1	0.14	0.93	0.39	-0.23	0.49	0.36	0.6	0.61	0.47	0.17	0.42	0.4	0.48	0.52	0.57		0.63	0.44	0.3	0.76	0.15	0.59
Inventory	0.95	0.96	0.91	0.39	0.74	0.46	0.84	-0.79	0.93	0.86	0.56	0.99	0.96	0.8	0.88	0.63	0.51	0.43	0.96	0.63		0.35	0.86	0.69	0.22	0.21
Other Current Assets	0.27	0.24	0.14	-0.29	0.04	0.46	0.22	-0.11	0.28	0.23	-0.04	0.37	0.18	0.05	0.14	0.81	0.38	0.31	0.23	0.44	0.35		0.0	0.42	0.05	0.25
Property Plant And Equipment Gross	0.85	0.84	0.95	0.73	0.83	0.1	0.78	-0.84	0.84	0.82	0.34	0.87	0.95	0.94	0.88	0.5	0.21	0.14	0.91	0.3	0.86	0.0		0.38	0.28	0.04
Total Current Assets	0.76	0.73	0.57	-0.04	0.49	0.56	0.75	-0.57	0.76	0.72	0.83	0.68	0.61	0.39	0.65	0.37	0.9	0.87	0.64	0.76	0.69	0.42	0.38		0.1	0.38
Short Term Debt	0.23	0.21	0.24	0.3	0.22	0.06	0.22	-0.31	0.23	0.22	0.02	0.22	0.24	0.28	0.27	0.22	0.01	0.04	0.32	0.15	0.22	0.05	0.28	0.1		0.0
Intangible Assets	0.22	0.33	0.14	-0.2	-0.12	0.53	0.17	-0.08	0.17	0.09	0.37	0.15	0.15	-0.05	0.2	0.11	0.26	0.21	0.28	0.59	0.21	0.25	0.04	0.38	0.0

Click cells to compare fundamentals

Bruker Account Relationship Matchups

Bruker fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.8B	3.0B	3.7B	3.6B	4.2B	4.5B
Total Stockholder Equity	917.1M	975.6M	1.1B	1.1B	1.4B	1.4B
Non Current Assets Total	975.2M	1.1B	1.2B	1.5B	2.1B	2.2B
Non Currrent Assets Other	16.8M	39.6M	70.8M	(99.8M)	175.7M	184.5M
Other Assets	77.3M	180M	160.9M	208.9M	240.2M	252.2M
Common Stock Shares Outstanding	156.6M	154.6M	152.9M	149.4M	147.2M	143.8M
Liabilities And Stockholders Equity	2.8B	3.0B	3.7B	3.6B	4.2B	4.5B
Non Current Liabilities Total	1.2B	1.3B	1.6B	1.6B	1.6B	1.7B
Other Stockholder Equity	(333.8M)	(436.3M)	(568.4M)	(816.8M)	(954.3M)	(906.6M)
Total Liab	1.9B	2.1B	2.6B	2.5B	2.8B	3.0B
Short Long Term Debt Total	860.3M	891.5M	1.3B	1.2B	1.4B	1.4B
Other Current Liab	388.8M	467.6M	481.2M	487.1M	454.9M	260.9M
Total Current Liabilities	645.6M	793.6M	938.5M	913.8M	1.2B	1.3B
Property Plant And Equipment Net	371.7M	462.9M	406.1M	487M	691.4M	726.0M
Net Debt	182M	209.7M	266M	573.7M	891.3M	935.9M
Retained Earnings	1.3B	1.4B	1.7B	1.9B	2.3B	2.4B
Accounts Payable	118.4M	134.6M	147.4M	182.3M	202.7M	212.8M
Cash	678.3M	681.8M	1.1B	645.5M	488.3M	311.3M
Cash And Short Term Investments	684.9M	731.8M	1.2B	645.5M	488.3M	358.2M
Net Receivables	362.2M	335.3M	416.9M	472.7M	621.8M	652.9M
Inventory	577.2M	692.3M	710.1M	803.7M	968.3M	1.0B
Other Current Assets	172M	165.5M	176.6M	202.6M	85.8M	113.8M
Property Plant And Equipment Gross	371.7M	462.9M	406.1M	487M	1.2B	1.3B
Total Current Assets	1.8B	1.9B	2.5B	2.1B	2.2B	1.1B
Accumulated Other Comprehensive Income	(25.5M)	3.7M	(8.2M)	14.8M	6M	5.7M
Short Term Debt	500K	2.2M	112.4M	18.7M	144.5M	151.7M
Intangible Assets	603.5M	229.1M	211.8M	270.9M	330.5M	196.5M
Other Liab	311M	389.4M	404.9M	318.2M	365.9M	384.2M
Long Term Debt	812.8M	842.3M	1.2B	1.2B	1.2B	1.2B
Short Term Investments	0.0	6.6M	50M	100M	12M	11.4M
Property Plant Equipment	306.1M	395.5M	406.1M	487M	560.1M	588.1M
Current Deferred Revenue	137.9M	189.2M	197.5M	225.7M	400M	420M
Treasury Stock	(543.8M)	(667M)	(820.3M)	(1.1B)	(976.5M)	(927.7M)
Good Will	293M	320.4M	339.5M	457.6M	582.6M	611.7M
Net Tangible Assets	491.5M	509.6M	312.5M	1.2B	1.4B	1.5B
Noncontrolling Interest In Consolidated Entity	10.3M	13.1M	14.1M	11.9M	13.7M	8.2M
Retained Earnings Total Equity	1.3B	1.4B	1.7B	1.9B	2.2B	2.3B
Long Term Debt Total	812.8M	842.3M	1.2B	1.2B	1.4B	1.4B

Pair Trading with Bruker

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bruker Stock

0.9	A	Agilent Technologies Financial Report 28th of May 2024	Pair Corr
0.84	ELEV	Elevation Oncology Earnings Call This Week	Pair Corr
0.61	ENVB	Enveric Biosciences Financial Report 20th of May 2024	Pair Corr

The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.

The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Bruker is a strong investment it is important to analyze Bruker's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bruker's future performance. For an informed investment choice regarding Bruker Stock, refer to the following important reports:

How To Invest In Bruker

Details

Is Bruker Stock a good investment?

Details

What is Bruker's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.

To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Bruker Stock analysis

When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.

	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Global Correlations Find global opportunities by holding instruments from different markets
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities

Is Bruker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bruker. If investors know Bruker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bruker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.127

Dividend Share

0.2

Earnings Share

2.9

Revenue Per Share

20.249

Quarterly Revenue Growth

0.206

The market value of Bruker is measured differently than its book value, which is the value of Bruker that is recorded on the company's balance sheet. Investors also form their own opinion of Bruker's value that differs from its market value or its book value, called intrinsic value, which is Bruker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bruker's market value can be influenced by many factors that don't directly affect Bruker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bruker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bruker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bruker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bruker Total Operating Expenses vs Net Income From Continuing Ops Analysis

Total Operating Expenses vs Net Income From Continuing Ops

Total Operating Expenses vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Total Operating Expenses

Net Income From Continuing Ops

Bruker fundamental ratios Correlations

Bruker Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bruker fundamental ratios Accounts

Pair Trading with Bruker

Moving together with Bruker Stock

Complementary Tools for Bruker Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.99	Total Assets
Short Long Term Debt Total	+ 0.99	Non Current Liabilities Total
Inventory	+ 0.99	Total Current Liabilities
Property Plant And Equipment Net	+ 0.98	Non Current Assets Total
Retained Earnings	+ 0.98	Non Current Assets Total
Total Liab	+ 0.98	Non Current Liabilities Total

Retained Earnings	- 0.96	Other Stockholder Equity
Other Stockholder Equity	- 0.96	Other Assets
Other Stockholder Equity	- 0.95	Non Current Assets Total
Short Long Term Debt Total	- 0.94	Other Stockholder Equity
Other Stockholder Equity	- 0.94	Non Current Liabilities Total
Net Debt	- 0.93	Other Stockholder Equity